Actavis Wants A Win In Testosterone Heart Attack Suit

By Mike Curley (August 13, 2021, 2:34 PM EDT) -- Actavis Inc. is asking an Illinois federal judge to end its jury trial and give it a win in a suit alleging its testosterone replacement drugs caused a man's heart attack, saying the man has failed to make his case and no reasonable jury would find the company responsible....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!